Purchased 2025 Convertible Notes in the 2025 convertible notes offering
| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
John C.M. Farquhar
Also a director
President, Chief Executive Officer & Director
|
54 | Not stated | Not stated | $5,989,882 | |
|
Vikram Verghese
Chief Financial Officer
|
42 |
Since 2023
3 years
|
2021 | $2,357,900 | |
|
Campbell D.K. Rogers
Chief Medical Officer
|
64 |
Since 2012
14 years
|
Not stated | Not reported | |
|
Marie L. Jones
Chief Accounting Officer
Title from the Form 4 dated Sep 8, 2026
|
Not stated | Not stated | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Purchased 2025 Convertible Notes in the 2025 convertible notes offering
Purchased 2025 Convertible Notes in the 2025 convertible notes offering
Purchased 2025 Convertible Notes in the 2025 convertible notes offering
Purchased 2025 Convertible Notes in the 2025 convertible notes offering
Purchased 2025 Convertible Notes in the 2025 convertible notes offering
Purchased 2025 Convertible Notes in the 2025 convertible notes offering
Purchased 2025 Convertible Notes in the 2025 convertible notes offering
Purchased 2025 Convertible Notes in the 2025 convertible notes offering
Converted $23.0 million of outstanding term loan indebtedness into 2025 Convertible Notes
Company issued warrants to purchase 185,407 shares of common stock, later adjusted to additional warrants
Hayfin net exercised all outstanding common stock warrants for 1,646,317 shares of common stock
Purchased 35,081,564 shares of Series F preferred stock in the Series F and F-1 financing
Purchased 8,068,125 shares of Series F-1 preferred stock in the Series F and F-1 financing
Purchased Series F and Series F-1 preferred stock in the Series F and F-1 financing
Purchased Series F and Series F-1 preferred stock in the Series F and F-1 financing
Purchased 4,169,444 shares of Series F preferred stock in the Series F and F-1 financing
Purchased 3,508,156 shares of Series F preferred stock in the Series F and F-1 financing
Purchased Series F and Series F-1 preferred stock in the Series F and F-1 financing
Non-executive employee of the Company since 2014 with overall cash compensation not exceeding the stated amount for 2023, 2024 and 2025
Loading...